Jing Liu

Dr. Jing Liu

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2022 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
YZYing Zhang
Ying Zhang
QLQian Lu
Qian Lu
NLNan Li
Nan Li
MXMing Xu
Ming Xu
TMTatsuo Miyamoto
Tatsuo Miyamoto
JLJing Liu
Jing Liu
Breast cancer metastasis is the main cause of cancer death in women, so far, no effective treatment has inhibited breast cancer metastasis. Sulforaphane (SFN), a natural compound derived from broccoli, has shown potential health benefits in many cancers. However, research on breast cancer metastasis is still insufficient. Here, we showed that SFN, including its two isomers of R-SFN and S-SFN, significantly inhibited TGF-β1-induced migration and invasion in breast cancer cells. Proteomic and phosphoproteomic analysis showed that SFN affected the formation of the cytoskeleton. Subsequent experiments confirmed that SFN significantly inhibited TGF-β1-induced actin stress fiber formation and the expression of actin stress fiber formation-associated proteins, including paxillin, IQGAP1, FAK, PAK2, and ROCK. Additionally, SFN is directly bound to RAF family proteins (including ARAF, BRAF, and CRAF) and inhibited MEK and ERK phosphorylation. These in vitro results indicate that SFN targets the RAF/MEK/ERK signaling pathway to inhibit the formation of actin stress fibers, thereby inhibiting breast cancer cell metastasis.

18 October 2023 in Life Sciences
Verified
Journal Article
Closed access
YWYunxiang Wang
Yunxiang Wang
BLBin Li
Bin Li
GLGuanting Liu
Guanting Liu
QHQipeng Han
Qipeng Han
YDYunpeng Diao
Yunpeng Diao
JLJing Liu
Jing Liu

20 January 2023 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
BLBin Li
Bin Li
WLWenlian Li
Wenlian Li
MZMeiling Zheng
Meiling Zheng
YWYunxiang Wang
Yunxiang Wang
YDYunpeng Diao
Yunpeng Diao
JLJing Liu
Jing Liu
Intestinal ischemia/reperfusion (II/R) injury is a common pathological process with high clinical morbidity and mortality. Autophagy plays an important role in the pathological development of II/R. Corilagin (CA) is a natural ellagitannin with various pharmacological effects such as autophagy regulation, antioxidant, and antiapoptosis. However, whether CA alleviates II/R injury is still unclear. In this study, we had found that CA significantly attenuated II/R induced intestinal tissue pathological damage, oxidative stress, and cell apoptosis in rats. Further studies showed that CA significantly promoted AMPK phosphorylation and sirt1 expression, and thus activated autophagy by upregulating protein expression of autophagy-related proteins Beclin1 and LC3II and promoting SQSTM1/P62 degradation both in vivo and in vitro. Inhibition of AMPK phosphorylation by its inhibitor compound C(CC) significantly abolished CA-mediated autophagy activation and the relievable effects on oxidative stress and apoptosis in vitro, suggesting the excellent protective activity of CA against II/R injury via AMPK/Sirt1-autophagy pathway. These findings confirmed the potent effects of CA against II/R injury, and provided novel insights into the mechanisms of the compound as a potential candidate for the treatment of II/R.

10 June 2019 in Natural Product Research
Verified
Journal Article
Closed access
JLJing Liu
Jing Liu
JJJun Jiang
Jun Jiang
JZJunwei Zong
Junwei Zong
BLBin Li
Bin Li
TPTaowen Pan
Taowen Pan
SWShouyu Wang
Shouyu Wang
Development of new effective antimicrobial drugs is still a big challenge to date due to microbial infection remains an inevitable problem against human health. In this study, fatty acids extract of Lucilia sericata larvae (LFAs) was obtained and evaluated by gas chromatograph-mass spectrometry (GC-MS), and its antibacterial activity against Staphylococcus aureus (S. aureus) and Streptococcus pneumoniae (S. pneumoniae) was investigated. We found that LFAs exhibited effective antibacterial activity against S. aureus and S. pneumoniae with minimal inhibitory concentrations (MICs) of 125 μg/mL and 100 μg/mL, respectively. The bacterial wall and membrane were the main targets, which was confirmed by fluorescence microscopy, scanning electron microscopy and transmission electron microscopy. Furthermore, a notable anti-biofilm activity against S. aureus and S. pneumoniae was also observed, which was able to both prevent biofilm formation and eradicate mature biofilms of these bacteria. As a promising antibacterial agent, LFAs showed good application prospects in clinical practice. GRAPHICAL ABSTRACT

23 November 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
WLWenlian Li
Wenlian Li
KYKejia Yang
Kejia Yang
BLBin Li
Bin Li
YWYunxiang Wang
Yunxiang Wang
JLJing Liu
Jing Liu
YDYunpeng Diao
Yunpeng Diao
Intestinal ischemia reperfusion (II/R) is a clinical emergency that frequently occurs in a variety of clinical conditions. Severe intestinal injury results in the release of cytotoxic substances and inflammatory mediators which can activate local inflammatory response and bacterial translocation. This triggers multi-organ failure, including lung injury, which is a common complication of II/R injury and contributes to the high mortality rate. Corilagin (Cor) is a natural ellagitannin found in a variety of plants. It has many biological and pharmacological properties, including antioxidant, anti-inflammatory and anti-apoptosis activities. However, no studies have evaluated the effects and molecular mechanisms of Cor in alleviating II/R-induced intestinal and lung damage. In this study, Cor was found to significantly alleviate II/R-induced pathological damage, inflammatory response, oxidative stress, NLRP3 inflammasome activation, and pyroptosis in intestinal and lung tissues both in vivo and in vitro. Further, Cor inhibited the NLRP3 inflammasome activation and pyroptosis in RAW264.7 and MLE-12 cells induced by LPS/nigericin and that in IEC-6 cells induced by nigericin, indicating an amelioration of Cor in II/R-induced intestinal and lung injury via inhibiting NLRP3 inflammasome activation and pyroptosis. Thus, Cor might be a potential therapeutic agent for II/R-induced inflammation and tissue injury.

26 August 2024 in Phytomedicine
Verified
Journal Article
Closed access
YFYan-Li Feng
Yan-Li Feng
XXXin-Rong Xu
Xin-Rong Xu
QZQi-Meng Zhu
Qi-Meng Zhu
JCJing Chang
Jing Chang
HZHui-Lin Zhang
Hui-Lin Zhang
CSChengpeng Sun
Chengpeng Sun